Apyx Medical (APYX) Gross Profit (2016 - 2026)
Apyx Medical filings provide 15 years of Gross Profit readings, the most recent being $12.0 million for Q4 2025.
- On a quarterly basis, Gross Profit rose 33.86% to $12.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.0 million, a 12.55% increase, with the full-year FY2025 number at $33.0 million, up 12.55% from a year prior.
- Gross Profit hit $12.0 million in Q4 2025 for Apyx Medical, up from $8.3 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $12.2 million in Q4 2021 to a low of $5.7 million in Q1 2025.
- Median Gross Profit over the past 5 years was $7.8 million (2023), compared with a mean of $7.9 million.
- Biggest five-year swings in Gross Profit: surged 259.79% in 2021 and later plummeted 32.18% in 2022.
- Apyx Medical's Gross Profit stood at $12.2 million in 2021, then tumbled by 32.18% to $8.2 million in 2022, then grew by 8.35% to $8.9 million in 2023, then grew by 0.39% to $9.0 million in 2024, then skyrocketed by 33.86% to $12.0 million in 2025.
- The last three reported values for Gross Profit were $12.0 million (Q4 2025), $8.3 million (Q3 2025), and $7.1 million (Q2 2025) per Business Quant data.